SIRPA and neoplasm: In addition to its function as an adaptive immune checkpoint on T cells, elevated CD47 expression on tumor cells can serve as an innate immune checkpoint by engaging its counter receptor signal regulatory protein-α (SIRPα), which is expressed on macrophages, neutrophils, dendritic cells, and activated NK cells [13,14,15].